Our results confirm previous observations regarding significant differences in terms of clinical phenotype between prePMF and ET patients [4, 17, 18], the former presenting with higher leukocyte and platelet counts, lower hemoglobin values, higher LDH and circulating CD34-positive cells, and higher incidence of palpable splenomegaly. The gene discussed is CD34; the disease is Splenomegaly.